Results 201 to 210 of about 51,741 (305)

Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses [PDF]

, 2022
Victoria Hall, Victor H. Ferreira, Heidi Wood, Matthew Ierullo, Beata Majchrzak-Kita, Kathy Manguiat, Alyssia Robinson, Vathany Kulasingam, Atul Humar, Deepali Kumar   +9 more
openalex   +1 more source

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Nature Medicine, 2022
Samuel M. S. Cheng, C. K. Mok, Yonna W Y Leung, S. Ng, K. Chan, F. Ko, Chunke Chen, K. Yiu, B. Lam, E. Lau, Ken K P Chan, L. Luk, John K. C. Li, L. Tsang, L. Poon, D. Hui, M. Peiris   +16 more
semanticscholar   +1 more source

Unremarkable antibody responses against various infectious agents after inoculation with the BNT162b2 COVID‐19 vaccine

, 2022
Kei Kozawa, Hiroki Miura, Yoshiki Kawamura, Yuki Higashimoto, Masaru Ihira, Tetsushi Yoshikawa   +5 more
openalex   +2 more sources

BNT162b2 Covid-19 Vaccine in Adolescents

New England Journal of Medicine, 2021
openaire   +2 more sources

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine [PDF]

, 2022
Floriane Gallais, Pierre Gantner, Delphine Planas, Morgane Solis, Timothée Bruel, Florian Pierre, Eric Soulier, Paola Rossolillo, Slim Fourati, Jean Sibilia, Olivier Schwartz, Samira Fafi‐Kremer   +11 more
openalex   +1 more source

Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine [PDF]

Neurological Sciences, 2021
Michele Trimboli, Pio Zoleo, Gennarina Arabia, Antonio Gambardella   +3 more
openaire   +2 more sources

Systems vaccinology of the BNT162b2 mRNA vaccine in humans

Nature, 2021
P. Arunachalam, Madeleine K. D. Scott, T. Hagan, Chunfeng Li, Yupeng Feng, F. Wimmers, Lilit Grigoryan, M. Trisal, V. Edara, L. Lai, S. Chang, A. Feng, Shaurya Dhingra, Mihir M Shah, Alexandra S. Lee, S. Chinthrajah, S. Sindher, V. Mallajosyula, F. Gao, Natalia Sigal, S. Kowli, Sheena Gupta, K. Pellegrini, G. Tharp, Sofia Maysel-Auslender, Sydney Hamilton, H. Aoued, K. Hrusovsky, M. Roskey, S. Bosinger, H. Maecker, S. Boyd, Mark M. Davis, P. Utz, M. Suthar, P. Khatri, K. Nadeau, B. Pulendran   +37 more
semanticscholar   +1 more source

Neurovascular Adverse Effects of Sars-Cov-2 Vaccination

Drug Design, Development and Therapy
Leonidas D Panos,1,2 Panagiotis Bargiotas,2 Georgios Hadjigeorgiou,2 Georgios D Panos3,4 1Department of Neurology, Bern University Hospital « Inselspital », Bern, Switzerland; 2Department of Neurology, School of Medicine, University of Cyprus, Nicosia ...
Panos LD, Bargiotas P, Hadjigeorgiou G, Panos GD   +3 more
doaj  

Antibodies against Receptor Binding Domain of SARS-CoV-2 spike protein induced by BNT162b2 vaccine: results from a pragmatic, real-life study

, 2021
Marcello Mariani, Maura Acquila, Gino Tripodi, Raffaele Spiazzi, Elio Castagnola   +4 more
openalex   +1 more source

Age, Sex and BMI Relations with Anti-SARS-CoV-2-Spike IgG Antibodies after BNT162b2 COVID-19 Vaccine in Health Care Workers in Northern Greece [PDF]

, 2023
Paraskevi Papaioannidou, Kalypso Skoumpa, Christos Bostanitis, Maria Michailidou, Theodouli Stergiopoulou, Ioannis Bostanitis, Maria Tsalidou   +6 more
openalex   +1 more source